Its because the biological drive toward weight regain overwhelms even intensive lifestyle efforts in most cases
"Obesity is a key therapeutic area for Pfizer, and the company has a robust pipeline of three clinical and several pre-clinical candidates
For both Blue Cross Blue Shield of Michigan (BCBSM) and Blue Care Network (BCN), book of business data shows this sharp increase as well
Diabetes Care 41 , 258266 (2017)
The condition of gastroparesis , [2,3] where gastric emptying is delayed by the drug, causing the stomach to take too long to empty its contents, [9-12] may contribute to some severe side effects and concerns about future gastrointestinal issues and diseases
Discover the transformative power of PatchMDs B12 Patch Dr